MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Endologix Company Profile (NASDAQ:ELGX)

Consensus Ratings for Endologix (NASDAQ:ELGX) (?)
Ratings Breakdown: 1 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Buy (Score: 2.90)
Consensus Price Target: $14.20 (14.70% upside)

Analysts' Ratings History for Endologix (NASDAQ:ELGX)
Show:
DateFirmActionRatingPrice TargetActions
6/13/2016Piper JaffrayReiterated RatingOverweight$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Canaccord GenuityUpgradeHold -> Buy$15.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016RBC CapitalBoost Price TargetOutperform$15.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016GuggenheimInitiated CoverageBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2016BTIG ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016BMO Capital MarketsReiterated RatingHold$11.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/4/2016JPMorgan Chase & Co.Initiated CoverageOverweight$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Credit SuisseLower Price TargetOutperform$16.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016Stifel NicolausLower Price TargetBuy$17.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Endologix (NASDAQ:ELGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/1/2016        
5/9/2016Q1($0.24)($0.25)$38.78 million$42.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2016Q4($0.16)($0.17)$39.97 million$39.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/26/2015Q315($0.14)($0.13)$38.12 million$38.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2015Q215($0.13)($0.18)$39.47 million$39.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q115($0.13)($0.14)$37.94 million$36.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q414($0.10)($0.11)$38.10 million$38.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.13)($0.13)$37.00 million$37.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014Q214($0.08)($0.06)$36.50 million$38.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114($0.08)($0.08)$32.24 million$33.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.05)($0.05)$35.80 million$35.25 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q313($0.05)$0.01$32.47 million$33.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013($0.06)($0.03)$33.94 million$34.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q1 2013($0.06)($0.15)$29.26 million$29.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2013Q4 2012($0.03)($0.09)$29.03 million$29.22 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012($0.04)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012($0.04)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012($0.06)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2012($0.05)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011($0.05)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Endologix (NASDAQ:ELGX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.24)($0.24)($0.24)
Q2 20161($0.22)($0.22)($0.22)
Q3 20161($0.18)($0.18)($0.18)
Q4 20161($0.14)($0.14)($0.14)
(Data provided by Zacks Investment Research)
Dividend History for Endologix (NASDAQ:ELGX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Endologix (NASDAQ:ELGX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/3/2016Gregory D WallerDirectorSell7,800$12.86$100,308.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Amanda L DepalmaVPSell689$12.55$8,646.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016John D McdermottCEOSell6,116$12.55$76,755.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Joseph A DejohnInsiderSell957$12.55$12,010.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Robert D MitchellPresidentSell2,294$12.55$28,789.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2016James Edward MachekVPSell6,500$12.76$82,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2016Charles Steele LoveVPSell4,280$7.72$33,041.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Guido J NeelsDirectorBuy11,000$9.32$102,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Todd AbrahamVPBuy2,500$8.85$22,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015John D McdermottCEOBuy20,000$8.90$178,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015Jose A LimaVPSell1,923$12.60$24,229.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2015Thomas WilderDirectorSell3,790$16.08$60,943.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Jose A LimaVPSell1,872$16.75$31,356.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015Robert D MitchellPresidentSell45,000$17.33$779,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Charles Steele LoveVPSell10,000$13.95$139,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014Charles Steele LoveVPBuy2,000$11.70$23,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014Guido J NeelsDirectorBuy10,000$11.21$112,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014John D McdermottCEOBuy25,000$11.25$281,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Thomas WilderDirectorSell3,500$13.68$47,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2014Robert D MitchellPresidentSell18,271$14.23$259,996.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Robert D MitchellPresidentSell8,516$14.20$120,927.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Stefan SchreckVPSell25,000$16.18$404,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Stefan SchreckVPSell29,000$15.88$460,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Gary SorsherVPSell12,483$15.98$199,478.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013John McdermottCEOSell165,000$16.00$2,640,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Todd AbrahamVPSell9,994$15.90$158,904.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013John D McdermottCEOSell15,000$15.83$237,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Thomas WilderDirectorSell22,500$13.25$298,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Leonard M GreensteinVPSell1,253$14.01$17,554.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2012Robert John KristCFOSell37,530$14.06$527,671.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Endologix (NASDAQ:ELGX)
DateHeadline
06/23/16 02:46 PMEndologix, Inc. (NASDAQ:ELGX) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 06:17 AMEarnings Recap: Endologix Inc. (NASDAQ:ELGX) - iStreetWire
06/23/16 06:17 AMRecently Issued Stock Ratings For Endologix, Inc. (NASDAQ:ELGX) - Fiscal Standard
06/15/16 03:53 PMAnalysts and Technical Report on Endologix Inc (NASDAQ:ELGX) - Street Report
06/14/16 08:38 AMStocks Earnings Review: Endologix Inc. (NASDAQ:ELGX), Wynn Resorts Ltd. (NASDAQ:WYNN) - Beacon Chronicle
06/14/16 08:38 AMEndologix (ELGX) Is Today's Strong On High Volume Stock - TheStreet.com
06/13/16 03:35 PMPrice Target Summary Report: Pinnacle Foods Inc. (NYSE:PF), Endologix Inc. (NASDAQ:ELGX) - Beacon Chronicle
06/13/16 11:58 AMEndologix System Could Be ‘Game Changer’ In Aneurysm Repair -
06/13/16 07:12 AMAnalysts' Actions -- Agios Pharma, Concho Resources, Occidental, Sprouts and More -
06/11/16 07:40 AMTrend Of Rating Given To Endologix, Inc. (NASDAQ:ELGX) - Investor Newswire
06/11/16 07:40 AMAnalysts Reviewing Stocks: Endologix, Inc. (NASDAQ:ELGX) , Cigna Corporation (NYSE:CI) - Street Updates
06/10/16 07:46 AMEarnings Overview of the Stocks: Endologix Inc. (NASDAQ:ELGX), Colgate-Palmolive Co. (NYSE:CL) - Beacon Chronicle
06/09/16 09:54 PMBest Stocks for Investors: Endologix Inc. (NASDAQ:ELGX), CMS Energy Corp. (NYSE:CMS) - Beacon Chronicle
06/09/16 03:52 PMEndologix Inc. (NASDAQ:ELGX) Fundamental Star Rating Report - CML News
06/09/16 11:09 AMStocks inside Traders Spotlight: Endologix, Inc. (NASDAQ:ELGX) , Incyte Corporation (NASDAQ:INCY) - Street Updates
06/09/16 08:49 AMEndologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy - [at noodls] - June 9, 2016 Results Presented at 2016 Society of Vascular Surgery Annual Meeting IRVINE, Calif., June 09, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments ...
06/09/16 08:34 AM9:34 am Endologix announces 'positive' clinical data from the Italian Research Nellix Endoprosthesis study at the 2016 Society of Vascular Surgery annual meeting -
06/08/16 02:46 PMBuy Stocks for Investors: Endologix Inc. (NASDAQ:ELGX), Intrepid Potash, Inc. (NYSE:IPI) - Beacon Chronicle
06/08/16 08:12 AMTrending Stock Analysis: Endologix Inc. (NASDAQ:ELGX) - News Oracle
06/07/16 09:29 PMENDOLOGIX INC. (NASDAQ:ELGX) Financial Condition Compared to S&P 500 - CML News
06/07/16 03:55 PMAnalyst Recommended Buy These Stocks: Endologix Inc. (NASDAQ:ELGX), Deutsche Bank AG (NYSE:DB) - Beacon Chronicle
06/07/16 05:02 AMENDOLOGIX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
06/06/16 03:42 PMEndologix, Inc. (NASDAQ:ELGX) & Lion Biotechnologies (NASDAQ:LBIO) healthcare - Wall Street 24
06/06/16 03:42 PMAnalyst Recommended Stock: Endologix Inc. (NASDAQ:ELGX) - News Oracle
06/06/16 07:08 AMNotable HC Stocks Preview: Endologix, Inc. (NASDAQ:ELGX), Express Scripts Holding Company (NASDAQ:ESRX) - share market updates (press release)
06/03/16 08:23 AM957 Shares of Endologix, Inc. (ELGX) Stock are sold by Joseph A. Dejohn - Let Me Know About This - 957 Shares of Endologix, Inc. (ELGX) Stock are sold by Joseph A. DejohnLet Me Know About ThisEndologix logo Endologix, Inc. (NASDAQ:ELGX) insider Joseph A. Dejohn sold 957 shares of the company's stock in a transaction on Wednesday, June 1st. The stock was sold at an average price of $12.55, for a total value of $12,010.35. Following the sale ...Endologix, Inc. (NASDAQ:ELGX)'s Insider John Mcdermott Sold 6116 SharesFranklin IndependentEndologix, Inc. (NASDAQ:ELGX) Trading Up - Insiders Selling, Short Interest GrowingFinance Dailyall 10 news articles »
06/03/16 08:15 AMEndologix to Present at Jefferies Healthcare Conference - [at noodls] - June 3, 2016 IRVINE, Calif., June 03, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the ...
06/02/16 03:57 PMTrending Biotech Stocks Update: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Endologix, Inc. (NASDAQ:ELGX) - Is stories - Trending Biotech Stocks Update: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , Endologix, Inc. (NASDAQ:ELGX)Is storiesIn most recently trading session on 6/1/2016, Endologix, Inc. (NASDAQ:ELGX) climbed +0.16% while traded on 2.56 million shares versus it's an average volume of 1.03 million shares. The company recorded the last trade with the price of $12.69. The stock ...and more »
06/02/16 03:57 PM6116 Shares of Stock are sold by Insider Selling: Endologix, Inc. (ELGX) CEO - Let Me Know About This - 6116 Shares of Stock are sold by Insider Selling: Endologix, Inc. (ELGX) CEOLet Me Know About ThisEndologix logo Endologix, Inc. (NASDAQ:ELGX) CEO John D. Mcdermott sold 6,116 shares of Endologix stock in a transaction on Wednesday, June 1st. The shares were sold at an average price of $12.55, for a total value of $76,755.80. Following the ...James Machek, VP-Research & Development of Endologix, Inc. (NASDAQ:ELGX) Just Unloaded SharesFranklin IndependentEndologix, Inc. (NASDAQ:ELGX) Trading Up - Insiders Selling, Short Interest GrowingFinance Dailyall 6 news articles »
06/01/16 03:59 PMEarnings Trends of the Stock: Cousins Properties Incorporated (NYSE:CUZ), Endologix Inc. (NASDAQ:ELGX) - Beacon Chronicle - Earnings Trends of the Stock: Cousins Properties Incorporated (NYSE:CUZ), Endologix Inc. (NASDAQ:ELGX)Beacon ChronicleLast Trade: The Company closed its last session at $10.74 with the loss of -0.92%. The market capitalization of the company is $2.23 Billion, with the average Volume of 2.21 Million. The stock currently has its 52-Week High range of $10.96 and 52-week ...and more »
06/01/16 03:59 PMEndologix, Inc. (NASDAQ:ELGX) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Endologix, Inc. (NASDAQ:ELGX) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Endologix, Inc. (NASDAQ:ELGX). The latest reports which are currently in issue on Wednesday 1st of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, ...
05/31/16 08:46 AMStock Earnings Review: Grifols SA, Barcelona (GRFS), Endologix (ELGX) - Beacon Chronicle - Stock Earnings Review: Grifols SA, Barcelona (GRFS), Endologix (ELGX)Beacon ChronicleEndologix, Inc. (NASDAQ:ELGX) currently has High Price Target of $ 7.00. The Low and Mean Price Targets are $ 11.25 and $ 14.18 respectively. These price targets are a consensus analysis of 10 brokers. When having a look at Recommendation Trends of ...and more »
05/28/16 02:22 AMEarnings Review and Stock Rundown for Endologix, Inc. (NASDAQ:ELGX) - Wall Street Hints and News - Earnings Review and Stock Rundown for Endologix, Inc. (NASDAQ:ELGX)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Endologix, Inc. (NASDAQ:ELGX) to post ...and more »
05/28/16 02:22 AMAnalysts Review of Stocks: CVS Health Corporation (NYSE:CVS) , Endologix, Inc. (NASDAQ:ELGX) - Street Updates - Analysts Review of Stocks: CVS Health Corporation (NYSE:CVS) , Endologix, Inc. (NASDAQ:ELGX)Street UpdatesEndologix, Inc. (NASDAQ:ELGX) showed bullish move with gain of +3.33% after exchanging volume of 2.74 million shares in last trading session ended on 5/26/2016. The company recent traded volume was higher than its average volume of 980.86 ...and more »
05/28/16 02:22 AMEndologix, Inc. (NASDAQ:ELGX) & Minerva Neurosciences (NASDAQ:NERV) Healthcare Stock's Trend Analysis Report - Wall Street 24 - Endologix, Inc. (NASDAQ:ELGX) & Minerva Neurosciences (NASDAQ:NERV) Healthcare Stock's Trend Analysis ReportWall Street 24On Thursday, Shares of Endologix, Inc. (NASDAQ:ELGX) gained 3.33% to $12.73. The share price is trading in a range of $12.33 – $12.93. The stock exchanged hands with 2.74 Million shares contrast to its average daily volume of 1.24 Million shares.and more »
05/28/16 02:22 AMThe VP-Research & Development of Endologix Inc (NASDAQ: ELGX) is Selling Shares - Analyst Ratings - iStreetWireThe VP-Research & Development of Endologix Inc (NASDAQ: ELGX) is Selling SharesAnalyst RatingsToday, the VP-Research & Development of Endologix Inc (NASDAQ: ELGX), James Edward Machek, sold shares of ELGX for $82.94k. In addition to James Edward Machek, 6 other ELGX executives reported Sell trades in the last month. Based on Endologix ...Analysts: Endologix, Inc. (NASDAQ:ELGX) Stock Could Go to 17.00CWRU ObserverEndologix, Inc. (NASDAQ:ELGX) Closes At $12.73Enterprise LeaderEndologix, Inc. (NASDAQ:ELGX): Focus Stock Earnings and Rating ReviewFranklin IndependentWall Street Hints and News -Market Digest -Risers & Fallersall 12 news articles »
05/28/16 02:22 AMEndologix Inc. (ELGX) is Trading Higher on Unusual Volume for May 26 - Equities.com - Endologix Inc. (ELGX) is Trading Higher on Unusual Volume for May 26Equities.comEndologix Inc. (ELGX) experienced unusually high volume on May. 26, as the stock gained 3.33% to a closing price of $12.73. The stock saw 2.74 million shares trade hands over the course of the day on 13,453 trades. Given that the stock's average daily ...and more »
05/27/16 09:13 PMEarnings Estimates under Spotlight: Palo Alto Networks Inc (NYSE:PANW) - Endologix Inc. (NASDAQ:ELGX) shows upbeat performance surged 3.33% during the previous trading session. Brokerage firms on the street have price targets on the name ranging from $164.00 to $225.00 based on 38 opinions. The stock is now holding above its 50 ...
05/26/16 09:04 PMPortfolio Of Healthcare Movers: Endologix, Inc. (NASDAQ:ELGX), Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) - Is stories - Portfolio Of Healthcare Movers: Endologix, Inc. (NASDAQ:ELGX), Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI)Is storiesIn most recently trading session on 5/25/2016, Endologix, Inc. (NASDAQ:ELGX) climbed +2.41% while traded on 2.05 million shares versus it's an average volume of 949.61 thousand shares. The company recorded the last trade with the price of $12.32.and more »
05/26/16 09:04 PMTop Stories: Endologix, Inc. (NASDAQ:ELGX) - The Point Review - The Point ReviewTop Stories: Endologix, Inc. (NASDAQ:ELGX)The Point ReviewShare of Endologix, Inc. (NASDAQ:ELGX) traded on 3.17 percent above secure line at 3:23PM EDT in order to take the company's stock at the price of $12.71. At the time of writing the stock exchanged hands 1.46 million shares versus average trading ...Endologix (ELGX) Announces Positive EVAS FORWARD-IDE Study Data; 100% Procedural Tech Success AchievedStreetInsider.comEndologix Shares Rise 4% After EndoVascular Aneurysm Sealing Study Meets Endpoint (NASDAQ:ELGX)Sonoran Weekly ReviewEndologix Reveals Positive Clinical Data From Nellix EVAS FORWARD-IDE StudyBenzingaall 5 news articles »
05/26/16 12:49 PMEndologix Reveals Positive Clinical Data From Nellix EVAS FORWARD-IDE Study - Endologix, Inc. (NASDAQ: ELGX) revealed positive clinical data from the Nellix investigational device exemption (IDE) clinical study, the EVAS FORWARD-IDE Study. According to the company, this multicenter, prospective, single arm clinical study is meant to assess the safety and effectiveness of the Nellix EndoVascular Aneurysm Sealing System for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA"). Endologix said the data from the EVAS FORWARD-IDE study illustrated that the Nellix EVAS System met the study primary endpoints for major ...Full story available on Benzinga.com
05/26/16 08:17 AMEndologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study - [at noodls] - May 26, 2016 EVAS FORWARD-IDE Meets Primary and Secondary Endpoints; Additional Data to be Presented at SVS Meeting on June 11 IRVINE, Calif., May 26, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), ...
05/24/16 10:54 AMLast Analysts Rating Review: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , Endologix, Inc. (NASDAQ:ELGX) - Street Updates - Last Analysts Rating Review: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , Endologix, Inc. (NASDAQ:ELGX)Street UpdatesCelator Pharmaceuticals Inc. (NASDAQ:CPXX) accumulated +5.44%, closing at $17.82 after floating between $16.80 and $18.18. The company has market capitalization of $756.82M. It has twelve month low of $1.12 and twelve month high of $18.18.and more »
05/22/16 06:50 PMNext Weeks Broker Price Targets For Endologix, Inc. (NASDAQ:ELGX) - Share Trading News - Next Weeks Broker Price Targets For Endologix, Inc. (NASDAQ:ELGX)Share Trading NewsEndologix, Inc. has a 50 day moving average of 10.68 and a 200 day moving average of 9.35. The stock's market capitalization is 1.00B, it has a 52-week low of 6.51 and a 52-week high of 17.02. The share price of the company (NASDAQ:ELGX) was up ...
05/21/16 06:52 PMEndologix Inc. (ELGX) is Trading Higher on Unusual Volume for May 18 - Equities.com - Endologix Inc. (ELGX) is Trading Higher on Unusual Volume for May 18Equities.comEndologix Inc. (ELGX) experienced unusually high volume on May. 18, as the stock gained 2.04% to a closing price of $11.99. The stock saw 1.66 million shares trade hands over the course of the day on 12,840 trades. Given that the stock's average daily ...Healthcare Stock Analyst Roundup: Endologix (ELGX)News OracleRevenue Update on Endologix(NASDAQ:ELGX)Trade Callsall 3 news articles »
05/21/16 01:06 AMShare Recap and Earnings Focus on Endologix, Inc. (NASDAQ:ELGX) - Wall Street Hints and News - Share Recap and Earnings Focus on Endologix, Inc. (NASDAQ:ELGX)Wall Street Hints and NewsPresently, covering analysts are anticipating Endologix, Inc. (NASDAQ:ELGX) to report quarterly EPS of $-0.21. The company's next earnings report is expected to be released on or around 2016-08-01 for the period ending on 2016-06-30. The company ...and more »
05/20/16 07:56 PMMoving Healthcare Focused Stocks: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , Endologix, Inc. (NASDAQ:ELGX) - Is stories - Is storiesMoving Healthcare Focused Stocks: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , Endologix, Inc. (NASDAQ:ELGX)Is storiesCelator Pharmaceuticals Inc. (NASDAQ:CPXX) began the transactions at $16.50 and seen positive move of +10.35% while the stock last trade documented at $16.63. On the other hand, its previous finishing price was noted at $15.07. The stock traded total ...and more »
05/20/16 07:56 PMHealthcare Stock Analyst Roundup: Endologix (ELGX) - News Oracle - Healthcare Stock Analyst Roundup: Endologix (ELGX)News OracleBy looking at Endologix, Inc. (NASDAQ:ELGX) YTD (year to date) performance, the stock shows Negative value of 21.21%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the stock is ...and more »
05/20/16 01:31 AMEndologix Inc. (NASDAQ:ELGX) Insiders Seem Vary About Prospects - Street Register - Endologix Inc. (NASDAQ:ELGX) Insiders Seem Vary About ProspectsStreet RegisterEndologix Inc. (ELGX) up 5.08 per cent in the past week, is under coverage of 10 analysts who collectively recommend a buy rating on stock. 8 of the analysts have a buy or better rating; the 0 sells versus 0 underperforms. The 10 equity analysts who ...
05/18/16 08:28 PMMix Momentum Detain Active Stocks- Endologix Inc. (NASDAQ:ELGX), Pfizer Inc. (NYSE:PFE), UBS Group AG (NYSE ... - Seneca Globe - Seneca GlobeMix Momentum Detain Active Stocks- Endologix Inc. (NASDAQ:ELGX), Pfizer Inc. (NYSE:PFE), UBS Group AG (NYSE ...Seneca GlobeEndologix Inc. (NASDAQ:ELGX) closed at $11.54 with moves up of 1.76% in last trading session. Endologix, Inc. (ELGX) reported that it has completed patient enrollment in the LIFE study, a multi-center post-market registry deinked to evaluate the ...Analyst Review: Endologix, Inc. (NASDAQ:ELGX)Risers & Fallersall 3 news articles »
About Endologix

Endologix logoEndologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Its EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: ELGX
  • CUSIP: 29266S10
Key Metrics:
  • Previous Close: $12.38
  • 50 Day Moving Average: $12.28
  • 200 Day Moving Average: $9.82
  • P/E Ratio: N/A
  • P/E Growth: -0.43
  • Market Cap: $1.01B
  • Current Quarter EPS Consensus Estimate: $-0.79 EPS
Additional Links:
Endologix (NASDAQ:ELGX) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha